ResMed Inc. (RSMDF) Total liabilities 2017–2026
ResMed Inc. (RSMDF) total liabilities at each fiscal year-end, per SEC filings.
$2.4BFY2026 · since FY2017: $1.5B → $2.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $2.4B | +7.9% |
| FY2025 | $2.2B | +9.9% |
| FY2024 | $2.0B | -23.4% |
| FY2023 | $2.6B | +51.1% |
| FY2022 | $1.7B | -5.8% |
| FY2021 | $1.8B | -11.9% |
| FY2020 | $2.1B | +2.7% |
| FY2019 | $2.0B | +102.5% |
| FY2018 | $1.0B | -33.4% |
| FY2017 | $1.5B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross profitRSMDF Gross marginRSMDF Operating incomeRSMDF Operating marginRSMDF Operating cash flowRSMDF Free cash flowRSMDF Capital expendituresRSMDF Return on equityRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Shareholders’ equityRSMDF overview →